Arcoma AB (Sweden) Top Management

ARCOMA Stock  SEK 10.45  0.20  1.88%   
Arcoma AB employs about 24 people. The company is managed by 5 executives with a total tenure of roughly 56 years, averaging almost 11.0 years of service per executive, having 4.8 employees per reported executive. Analysis of Arcoma AB's management performance can provide insight into the company performance.
Frida Robbe  Insider
Marketing Mang
Sanna Rydberg  Insider
Chief Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arcoma AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Arcoma AB Management Team Effectiveness

The company has return on total asset (ROA) of 0.0218 % which means that it generated a profit of $0.0218 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0423 %, meaning that it generated $0.0423 on every $100 dollars invested by stockholders. Arcoma AB's management efficiency ratios could be used to measure how well Arcoma AB manages its routine affairs as well as how well it operates its assets and liabilities.

Arcoma AB Workforce Comparison

Arcoma AB is number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is presently estimated at about 551. Arcoma AB holds roughly 24.0 in number of employees claiming about 4% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02.

Arcoma AB Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Arcoma AB Price Series Summation is a cross summation of Arcoma AB price series and its benchmark/peer.

Arcoma AB Notable Stakeholders

An Arcoma AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Arcoma AB often face trade-offs trying to please all of them. Arcoma AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Arcoma AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Frida RobbeMarketing MangProfile
Sanna RydbergChief OfficerProfile
Johan DahlbergChief OfficerProfile
Peter ReinliPres IMIX ADR LtdProfile
Nicklas JohanssonOperations ManagerProfile

About Arcoma AB Management Performance

The success or failure of an entity such as Arcoma AB often depends on how effective the management is. Arcoma AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Arcoma management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Arcoma management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscleskeleton, thoratic, pediatric, and traumaresus clinics. Arcoma AB is traded on Stockholm Stock Exchange in Sweden.
Please note, the presentation of Arcoma AB's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Arcoma AB's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Arcoma AB's management manipulating its earnings.

Arcoma AB Workforce Analysis

Traditionally, organizations such as Arcoma AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Arcoma AB within its industry.

Arcoma AB Manpower Efficiency

Return on Arcoma AB Manpower

Revenue Per Employee4.9M
Revenue Per Executive23.4M
Net Loss Per Employee311.4K
Net Loss Per Executive1.5M
Working Capital Per Employee625K
Working Capital Per Executive3M

Complementary Tools for Arcoma Stock analysis

When running Arcoma AB's price analysis, check to measure Arcoma AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcoma AB is operating at the current time. Most of Arcoma AB's value examination focuses on studying past and present price action to predict the probability of Arcoma AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcoma AB's price. Additionally, you may evaluate how the addition of Arcoma AB to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges